Scott Whitaker, president and CEO of AdvaMed, sits down with Market Pathways’ David Filmore to talk about hot topics in medtech policy, including the current situation with tariffs, future optimism for policies coming out of FDA and CMS, a Breakthrough Device coverage bill moving in Congress, AdvaMed at 50, and what to look and listen for at The MedTech Conference, in San Diego, October 5-8.

Read more about these topics in Market Pathways:

Medtech in Trumpland: Industry's DC Advocates Weigh In on Policy Paths Ahead

https://www.mystrategist.com/market-pathways/article/medtech_in_trumpland_advamed_and_mdma_leaders_weigh_in_on_policy_paths_ahead.html

MDUFA VI Watch: 5 Takeaways From the Public Launch of User Fee Reauthorization

https://www.mystrategist.com/market-pathways/article/mdufa_vi_watch_5_takeaways_from_the_public_launch_of_user_fee_reauthorization__.html

What’s Happening at CDRH? RIFs, Retirements, User Fees, and Unknowns

https://www.mystrategist.com/market-pathways/article/whats_happening_at_cdrh_a_look_at_post-rif_device_center_realities.html

TCET: Industry’s Underwhelmed, But It’s a New Tool to Tap Into

https://www.mystrategist.com/market-pathways/article/tcet_industrys_underwhelmed_but_its_still_a_new_tool_to_tap_.html